Instil Bio, Inc.
Instil Bio, Inc. is listed today as Instil Bio, Inc.: market value, financials and filings are on its company page.
Funding rounds
3 counted as startup funding. Open the number of investors for the round's details.
| Month | Raised | Raise | Size | Investors | Sold | Filing |
|---|---|---|---|---|---|---|
| Dec 2020 | $185 M | No. 3 | $50 to $250 million | equity | SEC | |
| Jun 2020 | $170 M | No. 2 | $50 to $250 million | equity | SEC | |
| Mar 2019 | $25 M | No. 1 | $10 to $50 million | equity | SEC |
Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.
How it makes money#
What its filings and its own website say, sentence by sentence, each with its source.
Instil Bio, Inc. chose not to state its revenue in its newest notice of a funding round (Feb 2021).
SEC Form D · Feb 2021
The industry group it chose in its notices: Biotechnology.
SEC Form D · Feb 2021
That is all the official record says: Instil Bio, Inc. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.
Products and services#
No products or services of Instil Bio, Inc. are on record.
Investors#
3 named in official filings. Open an investor to see everything it has backed.
| Investor | Kind | Amount | Round | Role | Source |
|---|---|---|---|---|---|
| Curative Ventures V LLC | Venture capital | not stated | not stated | Held Series A, B and C preferred stock, 10% owner (Form 3, 2021) | SEC Form 3 |
| Vivo Capital Fund IX, L.P. | Fund or asset manager | not stated | not stated | Held Series B and C preferred stock, 10% owner (Form 3, 2021) | SEC Form 3 |
| Vivo Capital IX, LLC | Fund or asset manager | not stated | not stated | Held Series B and C preferred stock, 10% owner (Form 3, 2021) | SEC Form 3 |
Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 3 rounds above had up to 26 investors.
Largest shareholders today
Institutions holding Instil Bio, Inc. shares, as of Sep 30, 2026.
- BML Capital Management, LLC$5 M9.52%
- Vivo Capital, LLC$2 M4.32%
- UBS Group AG$2 M3.39%
- Vanguard Capital Management LLC$1 M2.41%
- Millennium Management LLC$1 M1.53%
- Kalehua Capital Management LLC$1 M1.47%
- BlackRock, Inc.$0 M0.81%
- Nomura Asset Management International Inc.$0 M0.74%
- Geode Capital Management, LLC$0 M0.62%
- Renaissance Technologies LLC$0 M0.59%
- Jacobs Levy Equity Management, Inc$0 M0.50%
- LPL Financial LLC$0 M0.46%
- Vanguard Fiduciary Trust Co$0 M0.43%
- Morgan Stanley$0 M0.28%
- State Street Corp$0 M0.26%
Source: SEC Form 13F holdings reports · as of Sep 30, 2026. Value held and share of the company. All holders are on the company page.
Executives and directors
As the company named them in its notices. Directors of a funded startup are often partners of its investors.
| Name | Role | Named in |
|---|---|---|
| Bronson Crouch | Executive officer | Feb 2021 |
| Sandeep Laumas | Executive officer | Feb 2021 |
| Mariam Morris | Executive officer | Sep 2019 |
| Bronson Crouch | Director | Feb 2021 |
| George Matcham | Director | Feb 2021 |
| Gwen Binder | Director | Feb 2021 |
| Jack Nielsen | Director | Feb 2021 |
| Kent McGaughy | Director | Feb 2021 |
| Neil Gibson | Director | Feb 2021 |
| Nimish Shah | Director | Feb 2021 |
| Margo Roberts | Director | Sep 2019 |
| Robert Hawkins | Director | Sep 2019 |
Went public since 2021. Its SEC number is that of a company listed on a stock exchange.